«Second look» en el tratamiento endoscópico de hemorragia digestiva

Introduction: Based on the lack of a formal recommendation of a particular endoscopic technique for the treatment of gastrointestinal bleeding for Dieulafoy’s lesion. Objective: To evaluate the effectiveness and the impact on the prognosis of endoscopic injection therapy (adrenalin/polidocanol) applied two times («second look») in gastrointestinal bleeding for Dieulafoy’s lesion. Methods: Prospective studies, conducted at the regional hospital «Vicente Corral Moscoso» University of Cuenca. Eighteen patients diagnosed with gastrointestinal bleeding from Dieulafoy’s lesion, were separated into 2 groups: Group A with 9 patients, who received a single endoscopic injection therapy with adrenaline and polidocanol. And group B with 9 patients, who received the same treatment, in the first instance, and were subsequently subjected to new session 7 days later. We analyzed and compared the clinical, endoscopic and laboratory results, with follow-up for 6 months. Results: In both groups is achieving 100% of primary hemostasis. In Group A re-bleeding was present in 22% (2/9) and in Group B 100% (9/9) of pat patients had no further episodes of gastrointestinal bleeding. In both groups there were no complications secondary to endoscopic procedure performed. Conclusions: Endoscopic injection treatment with a solution of a sclerosing and vasoconstrictor is 100% effective for primary hemostasis. A single intervention has a 22% rate of re-bleeding. Applying a «second look» with new injection therapy based on a vasoconstrictor and a sclerosing is 100% effective in preventing re-bleeding without adverse side effects. © 2013 Asociación Mexicana de Endoscopia Gastrointestinal. Published by Masson Doyma México S.A. All rights reserved.